Industry News
Excerpt from the announcement: Montreal, Canada — March 19th, 2020 — The Montreal General Hospital Foundation, in collaboration with the Research Institute of the McGill University Health Centre (RI-MUHC), is launching a global innovation challenge, backed by a prize of $200,000 CAD. They are calling for teams to design a simple, low-cost, easy-to-manufacture and easy-to-maintain…
Read More
Excerpt from the article: By Laurie Halloran, CEO & Chairwoman of the Board, Halloran Consulting Group, Inc. While we have not yet seen any significant delays in regulatory approval of life science products to date, the impact of COVID-19 on global health authorities is continuing to evolve. We expect a variety of potential delays in…
Read More
Excerpt from the article: “In these unprecedented times, we know that controlling the spread of novel coronavirus requires social distancing and testing. While all of us are doing our parts to stay at home, there’s a lot of confusion, chaos and frustration surrounding coronavirus testing in the US. Before going further, I want to be…
Read More
Excerpt from the Article: A newly developed artificial intelligence (AI)-based system is highly accurate for detecting the novel coronavirus disease (COVID-19) on thoracic CT studies, according to research published online March 13 on arXiv.org. It can also quantify and track disease burden. Click the button below to read the entire article: Continue Reading The Article
Read More
Excerpt from the article: “Researchers from China have developed an artificial intelligence (AI) algorithm that accurately detects COVID-19 and differentiates it from community-acquired pneumonia and other lung diseases. They shared their results in an article published online March 19 in Radiology.” Click the button below to read the entire article! Continue To The Article
Read More
Excerpt from the article: “The World Health Organization says that at least 20 coronavirus vaccines are currently in development in the global race for a cure. The first human trial, by the Boston-based biotech firm Moderna, is already underway. “Going from not even knowing that this virus was out there, which we then identified it…
Read More
Excerpt from the article: “Today, as part of the U.S. Food and Drug Administration’s ongoing efforts to address the coronavirus outbreak (COVID-19), the agency issued a new policy that allows manufacturers of certain FDA-cleared non-invasive, vital sign-measuring devices to expand their use so that health care providers can use them to monitor patients remotely. The…
Read More
Excerpt from the article: “As a researcher who develops vaccines for emerging infectious diseases, UConn pathobiologist and associate professor Paulo Verardi pays close attention to the news. He was doing just that in mid-January when he noticed that a new coronavirus SARS-CoV-2, causing a disease now known as coronavirus disease 2019 or COVID-19, was starting…
Read More
Excerpt from the FDA News Release: Today, the U.S. Food and Drug Administration issued the first emergency use authorization for a point-of-care COVID-19 diagnostic for the Cepheid Xpert Xpress SARS-CoV-2 test. “The test we’re authorizing today will be able to provide Americans with results within hours, rather than days like the existing tests, and the…
Read More
Excerpt from the article: “At the Berlin X-ray source BESSY II, researchers have decoded the protein responsible for the replication of the corona virus. Analysing the 3D architecture allows the systematic development of drugs which inhibit the reproduction oft he virus.” Click the button below to read the entire article! Continue To The Article
Read More